Literature DB >> 14657027

Regulation of HIV-1 gene expression by histone acetylation and factor recruitment at the LTR promoter.

Marina Lusic1, Alessandro Marcello, Anna Cereseto, Mauro Giacca.   

Abstract

In HIV-1 infected cells, the LTR promoter, once organized into chromatin, is transcriptionally inactive in the absence of stimulation. To examine the chromosomal events involved in transcriptional activation, we analyzed histone acetylation and factor recruitment at contiguous LTR regions by a quantitative chromatin immunoprecipitation assay. In chronically infected cells treated with a phorbol ester, we found that acetylation of both histones H3 and H4 occurs at discrete nucleosomal regions before the onset of viral mRNA transcription. Concomitantly, we observed the recruitment of known cellular acetyl-transferases to the promoter, including CBP, P/CAF and GCN5, as well as that of the p65 subunit of NF-kappa B. The specific contribution of the viral Tat transactivator was assayed in cells harboring the sole LTR. We again observed nucleosomal acetylation and the recruitment of specific co-factors to the viral LTR upon activation by either recombinant Tat or a phorbol ester. Strikingly, P/CAF was found associated with the promoter only in response to Tat. Taken together, these results contribute to the elucidation of the molecular events underlying HIV-1 transcriptional activation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14657027      PMCID: PMC291826          DOI: 10.1093/emboj/cdg631

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  45 in total

1.  Dynamics of global histone acetylation and deacetylation in vivo: rapid restoration of normal histone acetylation status upon removal of activators and repressors.

Authors:  Yael Katan-Khaykovich; Kevin Struhl
Journal:  Genes Dev       Date:  2002-03-15       Impact factor: 11.361

Review 2.  Histone modifications in transcriptional regulation.

Authors:  Shelley L Berger
Journal:  Curr Opin Genet Dev       Date:  2002-04       Impact factor: 5.578

Review 3.  Cooperation between complexes that regulate chromatin structure and transcription.

Authors:  Geeta J Narlikar; Hua-Ying Fan; Robert E Kingston
Journal:  Cell       Date:  2002-02-22       Impact factor: 41.582

4.  Function and selectivity of bromodomains in anchoring chromatin-modifying complexes to promoter nucleosomes.

Authors:  Ahmed H Hassan; Philippe Prochasson; Kristen E Neely; Scott C Galasinski; Mark Chandy; Michael J Carrozza; Jerry L Workman
Journal:  Cell       Date:  2002-11-01       Impact factor: 41.582

5.  Visualization of in vivo direct interaction between HIV-1 TAT and human cyclin T1 in specific subcellular compartments by fluorescence resonance energy transfer.

Authors:  A Marcello; R A Cinelli; A Ferrari; A Signorelli; M Tyagi; V Pellegrini; F Beltram; M Giacca
Journal:  J Biol Chem       Date:  2001-08-14       Impact factor: 5.157

Review 6.  Multiple modes of transcriptional regulation by the HIV-1 Tat transactivator.

Authors:  A Marcello; M Zoppé; M Giacca
Journal:  IUBMB Life       Date:  2001-03       Impact factor: 3.885

7.  Counterregulation of chromatin deacetylation and histone deacetylase occupancy at the integrated promoter of human immunodeficiency virus type 1 (HIV-1) by the HIV-1 repressor YY1 and HIV-1 activator Tat.

Authors:  Guocheng He; David M Margolis
Journal:  Mol Cell Biol       Date:  2002-05       Impact factor: 4.272

8.  Structural basis of lysine-acetylated HIV-1 Tat recognition by PCAF bromodomain.

Authors:  Shiraz Mujtaba; Yan He; Lei Zeng; Amjad Farooq; Justin E Carlson; Melanie Ott; Eric Verdin; Ming-Ming Zhou
Journal:  Mol Cell       Date:  2002-03       Impact factor: 17.970

Review 9.  Diversity of acetylation targets and roles in transcriptional regulation: the human immunodeficiency virus type 1 promoter as a model system.

Authors:  Vincent Quivy; Carine Van Lint
Journal:  Biochem Pharmacol       Date:  2002-09       Impact factor: 5.858

Review 10.  Ordered recruitment: gene-specific mechanism of transcription activation.

Authors:  Maria Pia Cosma
Journal:  Mol Cell       Date:  2002-08       Impact factor: 17.970

View more
  120 in total

1.  Combinatorial latency reactivation for HIV-1 subtypes and variants.

Authors:  John C Burnett; Kwang-Il Lim; Arash Calafi; John J Rossi; David V Schaffer; Adam P Arkin
Journal:  J Virol       Date:  2010-03-31       Impact factor: 5.103

2.  CRISPR-mediated Activation of Latent HIV-1 Expression.

Authors:  Prajit Limsirichai; Thomas Gaj; David V Schaffer
Journal:  Mol Ther       Date:  2015-11-26       Impact factor: 11.454

3.  c-Myc and Sp1 contribute to proviral latency by recruiting histone deacetylase 1 to the human immunodeficiency virus type 1 promoter.

Authors:  Guochun Jiang; Amy Espeseth; Daria J Hazuda; David M Margolis
Journal:  J Virol       Date:  2007-08-01       Impact factor: 5.103

4.  Cell cycle arrest in G2 induces human immunodeficiency virus type 1 transcriptional activation through histone acetylation and recruitment of CBP, NF-kappaB, and c-Jun to the long terminal repeat promoter.

Authors:  Sylvain Thierry; Vincent Marechal; Michelle Rosenzwajg; Michèle Sabbah; Gérard Redeuilh; Jean-Claude Nicolas; Joël Gozlan
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

5.  Requirement for SWI/SNF chromatin-remodeling complex in Tat-mediated activation of the HIV-1 promoter.

Authors:  Céline Tréand; Isaure du Chéné; Vanessa Brès; Rosemary Kiernan; Richard Benarous; Monsef Benkirane; Stéphane Emiliani
Journal:  EMBO J       Date:  2006-04-06       Impact factor: 11.598

6.  Suv39H1 and HP1gamma are responsible for chromatin-mediated HIV-1 transcriptional silencing and post-integration latency.

Authors:  Isaure du Chéné; Euguenia Basyuk; Yea-Lih Lin; Robinson Triboulet; Anna Knezevich; Christine Chable-Bessia; Clement Mettling; Vincent Baillat; Jacques Reynes; Pierre Corbeau; Edouard Bertrand; Alessandro Marcello; Stephane Emiliani; Rosemary Kiernan; Monsef Benkirane
Journal:  EMBO J       Date:  2007-01-24       Impact factor: 11.598

7.  Inhibition of human immunodeficiency virus type 1 replication in latently infected cells by a novel IkappaB kinase inhibitor.

Authors:  Ann Florence B Victoriano; Kaori Asamitsu; Yurina Hibi; Kenichi Imai; Nina G Barzaga; Takashi Okamoto
Journal:  Antimicrob Agents Chemother       Date:  2006-02       Impact factor: 5.191

8.  CBF-1 promotes transcriptional silencing during the establishment of HIV-1 latency.

Authors:  Mudit Tyagi; Jonathan Karn
Journal:  EMBO J       Date:  2007-11-15       Impact factor: 11.598

Review 9.  HIV-1 transcription and latency: an update.

Authors:  Carine Van Lint; Sophie Bouchat; Alessandro Marcello
Journal:  Retrovirology       Date:  2013-06-26       Impact factor: 4.602

Review 10.  The multifaceted nature of HIV latency.

Authors:  Caroline Dufour; Pierre Gantner; Rémi Fromentin; Nicolas Chomont
Journal:  J Clin Invest       Date:  2020-07-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.